Seth Klarman’s hedge fund firm Baupost Group has filed a 13G with the SEC regarding shares of Paratek Pharmaceuticals (PRTK). Per the filing, Baupost now owns 12.04% of the company with over 1.7 million shares.
This is a newly disclosed equity position for the firm and the filing was…
Shared:
Twitter: LinkedIn: Facebook: